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The most prevalent disease-causing mutation of
CFTR is the deletion of Phe508 (DF508), which leads
todefects in conventionalGolgi-mediatedexocytosis
and cell surface expression. We report that DF508-
CFTR surface expression can be rescued in vitro
and in vivo by directing it to an unconventional
GRASP-dependent secretion pathway. An integrated
molecular and physiological analysis indicates that
mechanisms associated with ER stress induce cell
surface trafficking of the ER core-glycosylated wild-
type and DF508-CFTR via the GRASP-dependent
pathway. Phosphorylation of a specific site ofGRASP
and the PDZ-based interaction between GRASP and
CFTR are critical for this unconventional surface
trafficking. Remarkably, transgenic expression of
GRASP inDF508-CFTRmice restores CFTR function
and rescues mouse survival without apparent tox-
icity. These findings provide insight into how uncon-
ventional protein secretion is activated, and offer a
potential therapeutic strategy for the treatment of
cystic fibrosis and perhaps diseases stemming from
other misfolded proteins.
INTRODUCTION
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a cAMP-activated anion channel responsible for trans-
epithelial chloride and bicarbonate transport in the airway,
exocrine pancreas, intestine, and genitourinary systems (Park
et al., 2010; Quinton, 1999). CFTR also regulates other ion chan-
nels and transporters in these epithelia and functions as a central
regulator and mediator of fluid and ion secretion (Kunzelmann,
2001; Lee et al., 2007). Consequently, loss of CFTR function
resulting from gene mutations underlies a range of epithelial
disorders including the classical form of cystic fibrosis (CF),
chronic pancreatitis, and infertility in males (see the Cystic
Fibrosis Mutation Database, http://www.genet.sickkids.on.ca/746 Cell 146, 746–760, September 2, 2011 ª2011 Elsevier Inc.app/). CFTR is a glycoprotein that undergoes complex glycosyla-
tion as it passes through theGolgi-mediated conventional exocy-
tosis (Quinton, 1999;Ward et al., 1995). Therefore, the fully glyco-
sylated mature CFTR, also known as band C, is expressed at the
apical membrane of epithelial tissues (Amaral, 2004). The most
common mutation of CFTR, deletion of phenylalanine at position
508 (DF508) results in protein misfolding, retention in the endo-
plasmic reticulum (ER), and finally degradation by the ER-associ-
ated degradation (ERAD) pathway (Ward et al., 1995). As a result,
negligible amounts ofDF508-CFTR reach the plasmamembrane,
and DF508-CFTR remains in the ER core-glycosylated immature
form, also known as band B, in cells (Amaral, 2004).
Importantly,DF508-CFTR can function as aCl– channel once it
reaches the cell surface (Denning et al., 1992; Namkung et al.,
2005). Therefore, many pharmacological and molecular efforts
are invested in approaches to facilitate the membrane targeting
of DF508-CFTR (Becq, 2010). The efficacy of potential DF508-
CFTR correctors is often evaluated by their ability to enhance
the accumulation of band C (Roxo-Rosa et al., 2006), because
it is commonly assumed that the complex-glycosylated CFTR
is the only form expressed in the plasma membrane. However,
notably, recent studies (Luo et al., 2009; Rennolds et al., 2008)
and exploratory experiments presented here (Figure S1A avail-
able online) suggest that the core-glycosylated CFTR (band B)
can also reach the plasma membrane under certain conditions.
The trafficking pathways and molecular mechanisms associated
with this unconventionally traveled CFTR remain obscure.
The Golgi reassembly stacking proteins (GRASPs) were
identified as factors required for the stacking of Golgi cisternae
through in vitro assays (Barr et al., 1997). Two isoforms of
GRASP, GRASP55 and GRASP65, have been found in verte-
brates (Shorter et al., 1999), but their precise physiological
role remains elusive. GRASPs are largely dispensable for the
conventional anterograde protein transport (Schotman et al.,
2008). Interestingly, results from recent studies indicate that
GRASPs are involved in the unconventional secretion of proteins
that bypasses the Golgi in invertebrate models, although
GRASPs were initially known as Golgi-associated proteins. The
GRASP homologs in Dictyostelium and Drosophila mediate the
transport of acyl-coenzyme A-binding protein (AcbA) and
a-integrin, respectively, at specific developmental stages via
an unconventional Golgi-independent route (Kinseth et al., 2007;
Schotman et al., 2008). However, the signaling mechanisms that
activate this GRASP-dependent unconventional secretion are
largely unknown.
The unfolded protein response (UPR) is an intracellular
signaling pathway that is activated by the accumulation of
unfolded proteins in the ER (Wiseman et al., 2010). In the ER,
secretory and transmembrane proteins fold into their native
conformation and undergo posttranslational modifications im-
portant for their activity and structure (Schro¨der and Kaufman,
2005). Perturbations in ER folding capacity by the excessive
influx of nascent, unfolded polypeptides activate signaling
cascades in the cytosol via transmembrane sensor proteins in
the ER membrane. Currently, three arms of the ER stress sig-
naling, namely the inositol-requiring protein 1 (IRE1)-, PKR-like
ER localized eIF2a kinase (PERK)-, and activating transcription
factor 6 (ATF6)-mediated pathways, are known to mediate the
UPR (Schro¨der and Kaufman, 2005; Wiseman et al., 2010).
In the present study, we report a molecular mechanism
whereby ER stress-associated signals and GRASPs play critical
roles in theunconventional surface transport of core-glycosylated
wild-type (WT) and DF508 CFTRs. The selective activation of this
unconventional trafficking pathway would be a potential thera-
peutic strategy for the treatment of diseases arising from confor-
mational changes and transport defects of misfolded proteins.
RESULTS
Immature Core-Glycosylated CFTR Can Reach
the Plasma Membrane and Are Functional
at the Cell Surface
It has been suggested that reducing the incubation temperature
(27C) or treatment with the ER Ca2+-ATPase inhibitor thapsigar-
gin can induce the surface expression ofDF508-CFTR,mainly by
disrupting the function of ER quality control system (Denning
et al., 1992; Egan et al., 2002). We noted that these maneuvers
increased cell surface expression of core-glycosylated CFTR
(band B) as well as complex-glycosylated CFTR (band C) (Fig-
ure S1A). Therefore, in the first part of the present work, we
searched for the molecular mechanism mediating this unusual
CFTR trafficking to the plasma membrane.
To determine whether the ER form of CFTR can travel to
the cell surface, we blocked the conventional Golgi-mediated
exocytic pathway in HEK293 cells expressing WT and DF508
CFTR (Figure 1). Inhibition of the anterograde coat protein
complex II (COPII)-mediated ER-to-Golgi trafficking was
achieved by expression of the dominant-negative form of Sar1,
a critical component of the COPII complex (Russell and Stagg,
2010) (Figure 1A). Although the GDP-restricted Sar1-T39N
mutant completely blocked the maturation of WT-CFTR glyco-
sylation, the core-glycosylated WT-CFTR was still targeted
to the cell surface. Of note, DF508-CFTR, which did not travel
to cell surface in mock or WT-Sar1 transfected cells, reached
the cell surface when ER-to-Golgi trafficking was blocked by
the dominant-negative Sar1 mutant (Figure 1A).
The same findings were recapitulated when the conventional
ER-to-Golgi trafficking route was blocked by the dominant-
negative Arf1-Q71L mutant (Figure 1B) or by syntaxin 5 (STX5)overexpression (Figure 1C). Arf1 is a component of the COPI
complex. Although COPI principally mediates retrograde trans-
port from pre-Golgi and Golgi membranes to the ER, it also
affects the anterograde transport of vesiculotubular elements
from the ER to Golgi stacks (Yoo et al., 2002). STX5 is a target
soluble N-ethylmaleimide (NEM)-sensitive factor attachment
protein receptor (t-SNARE), which is specifically required for
the fusion of COPII transport vesicles with acceptor Golgi
membranes (Hong, 2005). Overexpression of STX5 inhibited
ER-to-Golgi traffic by disrupting the stoichiometric balance of
functional SNARE complexes (Gee et al., 2010; Yoo et al.,
2002). As shown in Figure 1C, overexpression of STX5, but not
STX13 (which is involved in endosome recycling), blocksmatura-
tion of CFTR complex-glycosylation. The results in Figure 1D
show that membrane trafficking of the human transferrin re-
ceptor 1, a type II membrane glycoprotein, is almost completely
blocked by the Sar1 and Arf1 mutants and by STX5 overexpres-
sion, indicating that conventional ER-to-Golgi transport is indeed
blocked by expression of these proteins in HEK293 cells.
Furthermore, surface expressed WT and DF508 CFTRs in cells
expressing the mutant Arf1-Q71L are endoglycosidase H-sensi-
tive (Figure 1E), which corroborates the notion that surface
expressed CFTRs are only ER core-glycosylated and a Golgi-
independent route mediates their surface trafficking. Lastly,
treatment with brefeldin A, a fungal metabolite that induces
a block in ER-to-Golgi transport and collapse of the Golgi
stacks by inhibiting the function of Arf (Helms and Rothman,
1992), also permitted and enhanced the surface expression of
core-glycosylated WT and DF508 CFTRs (Figures S1B and
S1C). Therefore, when ER-to-Golgi trafficking is blocked by
various conditions, the core-glycosylated WT and DF508 CFTRs
can nonetheless reach the plasma membrane.
To further substantiate our observation of targeting of core-
glycosylated CFTR to the plasma membrane, we evaluated the
surface expression of CFTR by a surface enzyme-linked immu-
nosorbent assay (ELISA) using extracellular HA epitope-tagged
CFTR constructs. As shown in Figure S2, results from cell
surface ELISA confirm the biotinylation results, including the
observations of enhanced surface expression of DF508-CFTR
by the ectopic expression of Sar1-T39N, Arf1-Q71L, and STX5.
Surface expression of CFTR after blockade of ER-to-Golgi trans-
port was also examined using immunofluorescencemicroscopy.
In control cells with membrane permeabilization (Figure 1F),
most of the WT-CFTR is expressed at the cell surface. When
conventional ER-to-Golgi trafficking was blocked by Arf1-
Q71L, a large amount of WT-CFTR is confined in the ER.
However, a significant fraction of WT-CFTR was still found on
the plasma membrane. More importantly, a significant amount
of DF508-CFTR, that was located only in the ER in control
cells, reached the cell surface when ER-to-Golgi trafficking
was blocked by Arf1-Q71L (Figure 1F). Surface expression of
DF508-CFTR induced by Arf1-Q71L was more evident in immu-
nostainings using nonpermeabilized cells (Figure 1G).
A key question is whether these immature, core-glycosylated
WT and DF508 CFTRs unconventionally transported to the cell
surface are functional. This was determined by measuring
CFTR-mediated Cl– current in HEK293 cells after ER-to-Golgi
blockade (Figures 1H and 1I). Currents generated by CFTRCell 146, 746–760, September 2, 2011 ª2011 Elsevier Inc. 747
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Figure 1. Surface Expression of Core-Glycosylated CFTR after the Blockade of ER-to-Golgi Traffic in HEK293 Cells
Bar graph values are mean ± SEM of indicated numbers. band B, immature ER core-glycosylated CFTR; band C, mature complex-glycosylated CFTR; *p < 0.05;
difference from DF508-CFTR alone.
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were confirmed by the following three characteristics: (1) activa-
tion of Cl– current by an elevation in cAMP levels (forskolin treat-
ment), (2) a linear I-V relationship, and (3) inhibition of Cl– current
by the CFTR inhibitor CFTRinh-172. As shown in Figure 1H, WT-
CFTR Cl– currents in cells with ER-to-Golgi blockade were
comparable to those in control cells. This result indicates that
the unconventionally traveled CFTR retains Cl– channel activity
at the cell surface. Most significantly, surface-expressed
DF508-CFTR due to blockade of ER-to-Golgi trafficking also
shows substantial Cl– current in approximately 40% of cells
examined (Figure 1I).
GRASPs Are Involved in the Unconventional Transport
of Core-Glycosylated CFTR to the Plasma Membrane
To characterize the unconventional trafficking route, we exam-
ined possible factors involved in the surface transport of core-
glycosylated WT and DF508-CFTR (Figures 2A and 2B). Incuba-
tion at a reduced temperature of 20C, which blocks trans-Golgi
network (TGN)-to-plasma membrane transport (Miller et al.,
1992), had no effect on the unconventional transport of core-gly-
cosylated CFTRs, while it blocked the conventional trafficking of
complex-glycosylated WT-CFTR (leftmost panel in Figure 2A).
However, the surface transport of core-glycosylated CFTRs
was blocked by treatments with NEM and nocodazole (second
and third panels in Figures 2A and 2B). NEM inhibits membrane
fusion by disrupting SNARE functions (Hong, 2005). Although
NEM may partially reduce surface expression of CFTR by inhib-
iting membrane recycling, a complete absence of unconvention-
ally transported core-glycosylated CFTR from the cell surface
suggests that NEM-sensitive factors are involved in this process.
Nocodazole depolymerizes microtubules. Thus, the pathway by
which core-glycosylated CFTR maneuvers to the plasma mem-
brane is NEM-sensitive and microtubule-dependent, but does
not appear to involve conventional TGN-to-plasma membrane
transport.
A mechanism that can induce exocytosis of the ER protein is
the direct fusion of ER membranes to the plasma membrane.
STX18, an ER-localized t-SNARE, is known to be involved in
ER-mediated phagocytosis, in which direct membrane fusion
between the ER and plasma membrane occurs (Hatsuzawa
et al., 2006). However, depletion of STX18 by small interfering
RNA (siRNA) did not alter the unconventional surface transport(A–C) Surface biotinylation of CFTR. Blockade of conventional ER-to-Golgi traffic
expression of the immature core-glycosylated form (band B) of wild-type (WT) an
fraction confirms cell surface protein-specific labeling in each experiment. The
cytosolic CFTR and aldolase A in the surface biotinylation blot as controls. An
construct.
(D) Surface biotinylation of human transferrin receptor 1 (hTFRC).
(E) Surface biotinylated WT and DF508 CFTRs were treated with endoglycosid
glycosylation, and with N-Glycosidase F (PNGase F) that deglycosylates all N-gl
(F and G) Immunocytochemistry in membrane permeabilized (F) or nonpermeabili
pEYFP-ER. Arrow head indicates surface expression of DF508-CFTR after block
(H) Whole-cell Cl currents of WT-CFTR. CFTR was activated by the adenylyl cyc
(10 mM). The current-voltage (I-V) relationships were obtained with a stepwise puls
as current densities.
(I) Whole-cell Cl currents of DF508-CFTR. Inset: Quantal analysis of CFTR chan
channel activity.
See also Figures S1 and S2.of CFTR (Figure S3A). In addition, siRNA- or dominant negative
mutation-mediated inhibition of STX3, Rab1, Rab6, and Rab11
that are all known to be involved in the cellular CFTR trafficking
(Tang et al., 2011), had no effect on the transport of core-glyco-
sylated CFTR to the cell surface (Figure S3).
Recently, the GRASP homologs in Dictyostelium and
Drosophila were reported to mediate the Golgi-independent un-
conventional transport of soluble cytosolic and integral mem-
brane proteins (Kinseth et al., 2007; Schotman et al., 2008). Of
the two mammalian GRASP isoforms, GRASP55 is expressed
in HEK293 cells (Figure 2C). To examine whether GRASP is
required for the surface transport of core-glycosylated CFTR,
we inhibited endogenous GRASP55 function by treatment
with either the dominant-negative GRASP55-G2A mutant or
GRASP55-specific siRNA (Figures 2D and 2E). The G2A muta-
tion causes membrane dissociation of GRASP by inhibiting its
myristoylation (Shorter et al., 1999). Inhibition of GRASP function
by the G2A mutation or by siRNA treatment did not alter the
conventional Golgi-mediated trafficking ofWT-CFTR (Figure 2D).
By contrast, inhibition of GRASP55 abolished the unconven-
tional membrane transport of WT and DF508 CFTRs induced
by the blockade of ER-to-Golgi trafficking (Figures 2D and 2E).
In addition, loss of GRASP function by G2A mutation or siRNA
treatment abolished the thapsigargin-induced surface expres-
sion of DF508-CFTR in CFPAC-1 and HEK293 cells (Figure S4).
These findings indicate that GRASPs play a critical role in the
surface trafficking of core-glycosylated CFTRs.
Physical Interaction between GRASP and CFTR
Next, we asked whether CFTR and GRASP interact with each
other. Figures 3A and 3B illustrate the domain structures of
CFTR and GRASP55 and the constructs made for the protein-
protein interaction studies. When coexpressed, GRASP55
does not interact with CFTR in a resting state. Notably, blockade
of the conventional exocytic route by Sar1-T39N or STX5 over-
expression resulted in an association between core-glycosylated
CFTR and GRASP55 (Figure 3C). Sequential truncation from the
C terminus indicate that a C-terminal region of CFTR (aa 1386–
1480) is responsible for its associationwithGRASP55 (Figure 3D).
Further analyses revealed that deletion of the PDZ (PSD-95/discs
large/ZO-1)-binding motif located at the very end of the C
terminus, but not deletion of N terminus of CFTR, abolished theby Sar1-T39N, Arf1-Q71L, and STX5 overexpression induces the cell surface
d DF508 CFTR. Absence of the cytosolic protein aldolase A in the biotinylated
cells in lanes 1 and 5 were permeabilized with Triton X-100 (0.05%) to show
ti-Myc or anti-HA blot represents the correct expression of each transfected
ase H (Endo H) that deglycosylates ER core-glycosylation but not complex-
ycan chains to remove carbohydrate residues from proteins (band A).
zed conditions (G). CFTR was costained with the ERmarker protein calnexin or
ade of the conventional ER-to-Golgi traffic by Arf1-Q71L.
lase activator forskolin (5 mM) and inhibited by the CFTR inhibitor CFTRinh-172
e from120 mV to +120 mV. Inset: Mean currents at80 mV were normalized
nel activity. Current densities greater than five were considered positive CFTR
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Figure 2. GRASP Is Involved in the Unconventional Trafficking of Core-Glycosylated CFTR
(A and B) HEK293 cells were transfected with WT (A) or DF508-CFTR (B), and surface biotinylated. STX5 overexpression or Arf1-Q71L was used to block
conventional trafficking. Twenty-four hours after transfection, batches of cells were (1) incubated at 20C for 24 hr, (2) incubated at 20C for 2 hr then treated with
N-ethylmaleimide (NEM; 1 mM) for 15 min and further incubated in serum-free media without NEM for 2 hr at 37C, or (3) treated with nocodazole (10 mM, 24 hr).
Data are shown as mean ± SEM. Other legends are the same as in Figures 1A–1C.
(C) Expression of GRASP55 and GRASP65 in various cell lines.
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interaction with GRASP (Figures 3E and 3F). Accordingly, the
results of pull-down assays with domain-specific GRASP55
proteins indicate that the first PDZ domain (PDZ1) of GRASP55
binds to the C terminus of CFTR (Figure 3G). Results in Figure 3H
show that deletion of the C-terminal PDZ binding motif of CFTR
(DC4) abolishes the ER-to-Golgi blockade- and thapsigargin-
induced surface expression of DF508-CFTR. Collectively, the
above results indicate that GRASP directly associates with
CFTR via the PDZ domain when ER-to-Golgi transport is
blocked, and that this PDZ-mediated interaction is critical for
the unconventional surface expression of core-glycosylated
CFTR via GRASP.
ER Stress Signaling Activates the GRASP-Dependent
Pathway and Induces Phosphorylation of GRASP
Next, we investigated how the blockade of ER-to-Golgi transport
activates the GRASP-dependent unconventional secretory
route. Several findings have implicated the involvement of the
ER stress response in the activation of this unconventional traf-
ficking. Blockade of the ER-to-Golgi transport including treat-
ment with brefeldin A leads to an accumulation of secretory
proteins in the ER lumen and induces UPR (Pahl, 1999). Thapsi-
gargin, which perturbs ER function by depleting ER lumenal
calcium stores, is also a well-known agent that induces UPR in
mammalian cells (Pahl, 1999). As shown in Figure S4, thapsigar-
gin induced the surface expression of core-glycosylated CFTR
via the GRASP-dependent pathway in CFPAC-1 and HEK293
cells. To directly analyze the induction of ER stress signaling,
we examined the expression of ER stress marker protein
CHOP (C/EBP-homologous protein). Significantly, blockade of
the ER-to-Golgi transport by the ectopic expression of STX5,
Arf1-Q71L, and Sar1-T39N evoked an induction of CHOP in
HEK293 cells (Figure 4A). Three different classes of ER stress
signal transducers, IRE1, PERK, and ATF6, have been identified
to mediate the UPR (Wiseman et al., 2010). Depletion of each
transducer by treatment with specific siRNAs revealed that the
IRE1-mediated signaling arm, but not those of PERK and
ATF6, is involved in the ER stress-induced exocytosis of core-
glycosylated CFTR (Figure 4B).
It has been shown that GRASPs are the substrates of specific
signaling cascades, such as the MKK/ERK pathway, and can
be phosphorylated during cell division (Jesch et al., 2001). There-
fore,weexaminedwhether theERstress-inducedcell signals can
affect the phosphorylation status of GRASP. Interestingly, cyto-
sols taken from cells treated with the ER stress-inducing agents
(nocodazole and thapsigargin) or cells transfected with the ER-
to-Golgi blockade-inducing plasmids evoked an upward shift of
recombinantGRASP55,principally theSPRdomainofGRASP55,
in a band-shift assay (Figure 4C). The control and upward-shifted
GRASP55 SPR domains were purified, trypsin-digested, and
subjected to a Q-TOF-MS (quadrupole time-of-flight tandem
mass spectrometry) analysis to find phosphorylation sites. The
tandem mass spectra revealed phosphorylation of the Ser441
residue with a high probability score (Figures 4D–4F).(D and E) The dominant-negative GRASP55-G2A mutant or GRASP55 depletion
(D) and DF508-CFTR (E). Cells in the right-hand panels were treated with equal a
See also Figures S3 and S4.GRASP Rescues DF508-CFTR in HEK293 Cells in an
IRE1- and Ser441 Phosphorylation-Dependent Manner
Next, we investigated whether GRASP upregulation can rescue
the defects caused by theDF508-CFTRmutation. Notably, over-
expression of GRASP55 or GRASP65 alone resulted in surface
expression of DF508-CFTR in HEK293 cells without significantly
inducing ER stress (Figure 5A and Figure S5). In addition, the
GRASP-induced, surface-expressed DF508-CFTR showed
typical CFTR Cl currents in whole-cell recording (Figure 5B).
As expected, the rescue of DF508-CFTR surface expression
and Cl channel activity by GRASP was abolished by deleting
the C-terminal PDZ ligand (DC4) of DF508-CFTR (Figures 5C
and 5D). These findings further support the notion that a specific
interaction with GRASP is important for the rescue of DF508-
CFTR.
Because IRE1-mediated signaling is required for the thapsi-
gargin-induced surface trafficking of DF508-CFTR (Figure 4B),
we tested whether the GRASP overexpression-induced traf-
ficking also requires IRE1. As shown in Figure 5E, depletion of
IRE1a inhibited the GRASP55 overexpression-induced surface
trafficking of DF508-CFTR. Furthermore, phosphorylation at
the Ser441 residue of GRASP55 was critical for this process.
Thus, the phospho-inhibiting mutation of S441A greatly dimin-
ished the GRASP55-induced DF508-CFTR surface trafficking,
while a phospho-mimicking mutation of S441D did not (Fig-
ure 5F). These results imply that phosphorylation of GRASP
that is associated with the basal activity of IRE1 is critically
involved in the GRASP-mediated surface trafficking of DF508-
CFTR. A recent study has suggested that the unconventional
GRASP-mediated secretion of P. pastoris Acb1 is dependent
on autophagosome formation (Manjithaya et al., 2010). In the
case of CFTR, depletion of components involved in the autopha-
gosome formation (ATG1, ATG5, ATG7, and ATG8), but not
in lysosome fusion (Vamp7), inhibited unconventional surface
trafficking of DF508-CFTR induced by thapsigargin or GRASP55
overexpression (Figure S6).
Transgenic Expression of GRASP Rescues DF508-CFTR
in Mice
To determine whether GRASP-mediated surface transport of
CFTR is indeedofpathophysiological relevance in vivo,weexam-
ined the effects of GRASP upregulation on DF508-CFTR trans-
port and activity in mice. Transgenic mice harboring GRASP55
(TgGRASP55) were generated and crossed with DF508-CFTR
mice (CftrF508 del) mice (Zeiher et al., 1995) (Figures 6A and 6B).
Mice homozygous for WT-CFTR or DF508-CFTR were used in
subsequent experiments. TgGRASP55 mice showed no signifi-
cant abnormalities in gross appearance up to the age of 1 year.
However, CftrF508 del mice exhibited marked growth retardation
as reported previously (Namkung et al., 2005; Zeiher et al.,
1995). Importantly, TgGRASP55 expression completely reversed
growth retardation of the CftrF508 del mice (Figures 6C and 6D).
All CftrF508 del mice survived for less than 10 weeks. Most
notably, TgGRASP55 expression greatly improved survival ofby siRNA treatment blocks the unconventional membrane trafficking of WT
mount of control scrambled or GRASP55-specific siRNA (100 nM).
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the CftrF508 del mice, resulting in only 5% (one out of 19) mortality
during the 3 month observation period (Figure 6E). However,
TgGRASP55 expression did not improve growth retardation
and mouse survival in CFTR null (Cftr/) mice (Figure S7), sug-
gesting that the effects of TgGRASP are not associated with
the background effects of transgene but are specifically related
to the rescue of misfolded CFTR.
The DF508-CFTR mutation predominantly induces an
intestinal pathology rather than respiratory defects inmice (Nam-
kung et al., 2005; Zeiher et al., 1995). A group of mice was there-
fore sacrificed at the age of 1 month, and intestinal tissues
were isolated for a functional assay. As shown in Figures 7A
and 7B, CFTR-dependent short circuit current (Isc), which is acti-
vated by forskolin and inhibited by the Na+-K+-2Cl cotrans-
porter inhibitor bumetanide, is critically reduced in the colon of
CftrF508 del mice. Notably, TgGRASP55 expression results in
resumption of CFTR-dependent Isc in the Cftr
F508 del mouse
colon, to 63% of the level in WT mice. Immunohistochemical
analyses further indicate that transgenic GRASP expression
rescues DF508-CFTR in mice (Figure 7C). In wild-type mice,
CFTR is expressed at the apical membrane of colonic crypt cells
and TgGRASP55 expression does not affect this pattern. The
apical expression of CFTR at colonic crypts was not observed
in CftrF508 del mice as reported earlier (Namkung et al., 2005;
Zeiher et al., 1995). Clearly, TgGRASP55 expression rescued
the apical expression of DF508-CFTR in crypt cells (Figure 7C).
Finally, surface biotinylation analyses with samples from mouse
colonic mucosa reveal that TgGRASP55 expression induces the
surface expression of core-glycosylated DF508-CFTR, but not
complex-glycosylated CFTR (Figure 7D). These results, taken
together, indicate that upregulation of GRASP55 expression
in vivo could effectively rescue the CF phenotype resulting
from DF508-CFTR mutation.
DISCUSSION
In the present study, we discovered that immature core-glycosy-
lated CFTR can travel to the plasma membrane via the GRASP-
dependent unconventional route, andmade use of this finding to
markedly improve the surface expression of DF508-CFTR and to
rescue the defects caused by the DF508-CFTR mutation in vitro
and in vivo. Several unique observations lead to these conclu-
sions. One of these is the surface expression of core-glycosy-
lated WT and DF508 CFTRs after ER-to-Golgi blockade. This
was shown by multiple assays, including surface biotinylation,
surface ELISA, and immunohistochemistry. Moreover, the ap-
pearance of Cl– channel activity typical of CFTR in cells withFigure 3. Protein-Protein Interactions between CFTR and GRASPs
(A and B) Schematic diagram of CFTR and GRASP constructs used in immuno
domain; TM, transmembrane domain; R, regulatory domain; SPR, serine/proline
(C) Protein samples were immunoprecipitated with anti-Myc (GRASP55) and imm
proteins were loaded into each lane, and immunoprecipitation was performed w
(D–F) Identification of CFTR domain that interacts with GRASP by using immunopr
not the deletion of N terminus (F), abolishes its interaction with GRASP55.
(G) Pull-down assays. Expression of glutathione-S-transferase (GST) and the GS
staining (uppermost panel). GST-pull-down assays were performed using 10 mg o
proteins. One microgram of each His6-tagged protein was loaded as an input co
(H) Deletion of C-terminal PDZ binding motif (DC4) abolishes cell surface expressER-to-Golgi blockade solidified presence of the Golgi-indepen-
dent membrane trafficking of WT and DF508 CFTRs (Figure 1).
GRASP65 and GRASP55 are two mammalian myristoylated
proteins initially shown to be involved in Golgi assembly (Barr
et al., 1997; Shorter et al., 1999). However, GrpA, the single
homolog of GRASP in D. discoideum, has been identified to
mediate the unconventional secretion of a soluble cytoplasmic
protein AcbA via a Golgi-independent route (Kinseth et al.,
2007). Similarly, D. melanogaster dGRASP is required for the
Golgi-independent membrane trafficking of integral plasma
membrane proteins (Schotman et al., 2008). The present study
extends these findings to show that mammalian GRASPs are
involved in the unconventional Golgi-independent membrane
trafficking using CFTR as a model.
An interesting question addressed here is how the blockade of
ER-to-Golgi traffic activates the GRASP-dependent unconven-
tional exocytosis. Several findings in the present study indicate
that ER stress signals are involved in this unconventional traf-
ficking. Transit from the ER to the Golgi complex is the rate-
limiting step in the secretion of many glycoproteins (Schro¨der
and Kaufman, 2005). Blockade of the conventional ER-to-Golgi
transport evoked an induction of the UPR marker protein CHOP
in HEK293 cells (Figure 4A). The well-known UPR-inducing
agents, thapsigargin and brefeldin A, induced GRASP-depen-
dent surface expression of core-glycosylated CFTR (Figures S1
and S4). Moreover, depletion of IRE1a abolished this unconven-
tional exocytosis (Figures 4B and 5E). In general, UPR decreases
the ER folding demand by inhibiting transcription and translation
of secretory proteins and by increasing clearance of unfolded
proteins through ERAD. UPR also increases the folding capacity
of the ER by promoting synthesis of ER-resident chaperones and
by increasing the size of the ER (Ron andWalter, 2007; Schro¨der
and Kaufman, 2005). In addition to these well-known functions,
thepresent results suggest that ERstressmayactivate the secre-
tion of ER proteins via the unconventional route to relieve the
protein burden. Further investigations with other forms of ER
stress, such as increased ER flux or treatments with tunicamycin
anddithiothreitol, will reveal thegeneral importanceof unconven-
tional trafficking in ER stress responses.
Upregulation of GRASP function alone resulted in surface
expression of DF508-CFTR without inducing the proapototic
CHOP signals in HEK293 cells (Figure 5 and Figure S5) and
rescued defects caused by DF508-CFTR without any apparent
toxicity in mice (Figures 6 and 7). Although the GRASP
overexpression-mediated pathway does not induce the CHOP
signals, it requires phosphorylation of the Ser441 residue that
is associated with the basal activity of IRE1 (Figures 5E and 5F).precipitation and pull-down assays. FL, full-length; NBD, nucleotide-binding
-rich.
unoblotted with anti-HA (CFTR). For immunoblotting of cell lysates, 50 mg of
ith a total of 500 mg of cell lysate.
ecipitation. Deletion of the C-terminal PDZ binding motif of CFTR (D and E), but
T-fused CFTR C-terminal 50 amino acids (Ct50) was visualized by Ponceau S
f purified recombinant His6-tagged GRASP55 domain and 20 mg of GST-fusion
ntrol. PDZ1 of GRASP55 shows the strongest interaction with CFTR.
ion of DF508-CFTR induced by ER-to-Golgi blockade or thapsigargin (TG).
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Figure 4. Activation of the Unconventional Trafficking of DF508-CFTR and Phosphorylation of GRASP by ER Stress Signals
(A) Induction of the ER stress marker protein CHOP (C/EBP-homologous protein) by the ER-to-Golgi blockade. HEK293 cells were harvested 18 hr after
transfection with indicated plasmids or after treatment with thapsigargin (TG) as described in Figure 1S. b-actin blot was used as a loading control.
754 Cell 146, 746–760, September 2, 2011 ª2011 Elsevier Inc.
A well-known function of IRE1 is the activation of the X-box
binding protein-1 (XBP1) transcription factor by its endonuclease
activity. However, metazoan IRE1 has signaling functions
beyond its nucleolytic activity. For example, mammalian IRE1
interacts with tumor necrosis associated factor 2 (TRAF2) and
activates the stress-induced Jun N-terminal kinase (JNK) (Urano
et al., 2000). Identification of the specific upstream kinase that
phosphorylates the Ser441 residue of GRASP55 would be a
critical task to selectively modulate the GRASP-dependent
unconventional exocytosis. Interestingly, mammals have two
IRE1 isoforms, IRE1a and IRE1b. Although the two isoforms
appear to have the same in vitro activities and subcellular local-
izations, gene deletion studies inmice revealed that only IRE1a is
essential for mammalian development (Bernales et al., 2006b;
Zhang et al., 2005). Whereas IRE1a is expressed in all mamma-
lian cells, IRE1b is expressed primarily in epithelial cells (Ber-
nales et al., 2006b). Therefore, it is tempting to speculate that
activation of IRE1bmay selectively induce the GRASP-mediated
surface trafficking of DF508-CFTR in epithelial cells.
Recent reports suggest that UPR activates autophagy path-
ways (Bernales et al., 2006a). In the present study, factors in-
volved in early autophagosome formation, but not those involved
in the late steps of lysosome fusion and degradation pathway,
appear to be associated with GRASP-mediated unconventional
exocytosis of CFTR in mammalian cells (Figure S6), similar to the
unconventional Acb1 secretion in yeast (Manjithaya et al., 2010).
However, whether CFTR and Acb1 are transported by the same
autophagy-dependent unconventional secretory mechanism is
unclear at the moment and remains to be further investigated.
Classical autophagy has been characterized primarily as a
degradative pathway of macromolecules and their recycling. A
growing body of evidence suggests that autophagy pathways
have other important cellular functions, ranging from antigen
presentation to unconventional protein secretion (Manjithaya
and Subramani, 2011). The present results imply that the inhibi-
tion of normal conventional secretion under stressed conditions
might activate unconventional secretion that selectively utilizes
autophagosomal components in mammalian cells. Previously,
it was suggested that CFTR can be unconventionally transported
from the ER to TGN via an STX5- and Arf1-independent pathway
in BHK andCHO cells (Yoo et al., 2002). However, the unconven-
tional ER-to-TGN pathway in BHK cells seems to be different
from the GRASP-mediated pathway described here in several
aspects. For example, the unconventional ER-to-TGN transport
in BHK cells is dependent on Sar1, and eventually complex-gly-
cosylated CFTR is expressed on the cell surface, while the(B) The ER stress-induced unconventional trafficking of DF508-CFTR is blocked
fection with control scrambled siRNA or siRNAs specific for IRE1a, PERK, and AT
confirmed by relevant immunoblotting or real-time PCR. Data are shown as mea
(C) Detection of GRASP55 phosphorylation using a band-shift assay. Recombinan
and 3G) were incubated with cytosol taken fromHEK293 cells (500 ml, for 60 min a
with DMSO (0.1%, solvent control), nocodazole (Noco), or thapsigargin (TG), or tr
upward shift of protein bands.
(D–F) Identification of the ER stress signal-induced phosphorylation site of GRASP
analysis. Purified GRASP55 SPR domains (10 mg) were separated by SDS-PAGE
excised from gels, trypsin-digested, and analyzed with Q-TOF to find phospho
detected a phospho peptide (S, phosphoserine). The phosphorylation site corre
among vertebrate GRASP55s. (E) and (F) represent tandem mass spectra and qunconventional pathway described in the present study is insen-
sitive to the dominant-negative Sar1 and transports core-glyco-
sylated CFTR to the cell surface. Nonetheless, the collective
results indicate that the classical secretory pathway traveling
through the ER, all sub-compartments of the Golgi, and secre-
tory vesicles is not the only route for cell surface trafficking of
CFTR.
Another notable and important finding of this study is the
directional transport of DF508-CFTR to the apical membrane
of colonic crypt cells in TgGRASP55 mice (Figure 7C). It has
been shown that dGRASP mediates the Golgi-independent
transport of integrin a subunit to a specific basolateral mem-
brane area, called the zone of contact, at specific developmental
stages in Drosophila (Schotman et al., 2008). Therefore, it seems
that the unconventional pathway mediated by GRASPs recog-
nizes specific sorting determinant of its cargo molecules and
facilitates their transport to the destined location in the plasma
membrane. Domain-specific interaction of GRASP and CFTR
(Figure 3) also supports the concept of cargo-specificity in the
GRASP-mediated tethering of cargo molecules.
We propose that GRASPs are one of the tethering factors
that (1) are involved in the ER stress-induced unconventional
secretion, (2) specifically associate with cargo molecules
through their PDZ domains, and (3) are activated by specific
upstream kinases. Future studies investigating the specific
upstream signals and downstream trafficking machinery should
identify pharmacologically suitable therapeutic targets to treat
diseases stemming from misfolded proteins with trafficking
defects. Although general upregulation of GRASP function by
transgenic gene expression sufficiently corrects the defects
caused by the DF508-CFTR mutation in mice, specific activa-
tion of native GRASP or related proteins should be considered
as an important therapeutic approach. Small molecules that
can reproduce the effect of GRASP overexpression will be
highly desirable and applicable for the treatment of human
patients with CF.
EXPERIMENTAL PROCEDURES
For a detailed description of all the methods, please see the Extended
Experimental Procedures and Table S1.
Cell Culture, Plasmids, siRNA, and Antibodies
HEK293 and CFPAC-1 cells were maintained in culture media supplemented
with serum and antibiotics. Information for plasmids, siRNAs, and antibodies
used in this study is available in the relevant sections of the Extended
Experimental Procedures.by the knockdown of IRE1a. Surface biotinylation was performed after trans-
F6 (50 nM each). Inset: A 75%–90% loss of each UPR transducer protein was
n ± SEM.
t full-length (FL) or domain-specific GRASP55 proteins (200 ng; see Figures 3B
t 37C) and immunoblotted with anti-His antibodies. HEK293 cells were treated
ansfected with each plasmid as described previously. Arrowheads indicate an
55 using the quadrupole time-of-flight tandemmass spectrometer (Q-TOF-MS)
and visualized via Coomasie blue staining (D). Then, the protein bands were
rylation sites. Product ion spectra obtained from samples of the TG-cytosol
sponds to the Ser441 residue of human GRASP55, which is highly conserved
uery results of the Mascot database, respectively.
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Figure 5. Rescue of DF508-CFTR by the Upregulation of GRASP in HEK293 Cells
Bar graph values are mean ± SEM.
(A and B) Heterologous expression of GRASP55 or GRASP65 induces the cell surface expression of DF508-CFTR and apparent CFTR Cl channel activities.
Insets in (B) and (D) represent quantal analysis of CFTR channel activity. Current densities greater than five were considered positive CFTR channel activity.
**p < 0.01; difference from DF508-CFTR alone.
(C and D) The GRASP-induced surface expression of DF508-CFTR (C) and its Cl channel activities (D) were abolished when the C-terminal PDZ binding motif of
DF508-CFTR was deleted (DC4). *p < 0.05; difference from DF508-CFTR alone,
#p < 0.05; difference from HA-DF508-CFTR + GRASP55.
(E) IRE1a is required for the GRASP55-mediated surface trafficking of DF508-CFTR. Surface expression of CFTR was examined after transfection with indicated
plasmids and the control scrambled or IRE1a siRNA (50 nM each). **p < 0.01.
(F) The phospho-inhibitingmutation of S441A inhibits theGRASP55-induced surface trafficking ofDF508-CFTR, while the phospho-mimickingmutation of S441D
does not. **p < 0.01.
See also Figures S5 and S6.
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Figure 6. Transgenic GRASP Expression Rescues Mouse Survival in CftrF508 del Mice
(A) Characterization of transgenic mice harboring GRASP55 (TgGRASP55). Immunoblot of various tissue lysates (60 mg) fromGRASP55-negative and GRASP55-
positive littermates of TgGRASP55mice. TgGRASP55-positivemice express transgenicMyc-hGRASP55, and its expression is an average of 3.7-fold higher than
that of endogenous GRASP55 in the colon. Lysates from HEK293 cells (10 mg) were used as a positive control for Myc-GRASP55.
(B) TgGRASP55(+) mice were crossed with heterozygous CftrF508 del mice, and four groups of mice homozygous for either WT-CFTR or DF508-CFTR in the F2
generation (red rectangle) were used in this study.
(C and D) Mouse growth. Mouse picture was taken at the age of 10 days (C), and body weight was quantified at the age of 30 days (D). CftrF508 del mice show
significant growth retardation, and TgGRASP55 expression restores weight gain. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01.
(E) Survival analyses. TgGRASP55 expression greatly improves the survival of CftrF508 del mice, resulting in 95% (18 out of 19) survival at the age of 12 weeks,
compared to 0% survival in control CftrF508 del mice. **p < 0.01.
See also Figure S7.Mice
CftrF508 del mice were obtained fromK.R. Thomas (University of Utah, Salt Lake
City, UT) (Zeiher et al., 1995) and Cftr/ (B6.129P2-Cftrtm1Unc/J) mice were
purchased from the Jackson Laboratory. TgGRASP55 mice were generated
in this study. CftrWT/F508 del and Cftr+/mice were crossed with TgGRASP55(+)
mice to express TgGRASP55 in mice homozygous for CftrF508 del/F508 del
or Cftr/.Immunoblotting, Immunoprecipitation, Pull-Down Assay,
and Immunofluorescence Staining
Immunoblotting and immunoprecipitation were performed as described previ-
ously (Gee et al., 2009). The pull-down assay was performed as described
previously (Lee et al., 2007). Immunofluorescence staining of mouse colons
was performed with anti-CFTR R4 rabbit polyclonal antibody as described
previously (Gee et al., 2010).Cell 146, 746–760, September 2, 2011 ª2011 Elsevier Inc. 757
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Figure 7. Transgenic GRASP Expression Rescues Surface Expression of DF508-CFTR and Isc in the Colon of Cftr
F508 del Mice
(A and B) Short circuit current (Isc) measurements in the mouse colon. Mice homozygous for WT-CFTR or ΔF508-CFTR at the age of 1 month were sacrificed
and Isc was measured. Forskolin (10 mM) application to the apical side evoked a lumen-negative Isc that is fully inhibited by basolateral application of the Na
+-K+-
2Cl cotransporter inhibitor bumetanide (100 mM). The apical side was treated with amiloride (100 mM) to block epithelial Na+ channels. TgGRASP55 expression
results in the apparent CFTR-dependent Isc in the Cftr
F508 del mouse colon. A summary of multiple experiments and representative traces of Isc measurements are
presented in panels (A) and (B), respectively. Values are mean ± SEM of indicated numbers. **p < 0.01.
(C) Immunostaining. Cross-sections of mouse colonic crypts were immunostained with anti-CFTR R4 rabbit polyclonal antibody. TgGRASP55 expression results
in the rescue of CFTR expression at the apical membrane of crypt cells in the CftrF508 del mouse colon. Arrowheads indicate the apical region of colonic crypts.
(D) Epithelial cells were harvested from colonic mucosa, and surface biotinylation was performed. Some cells were permeabilized with Triton X-100 (0.05%) to
show cytosolic CFTR and aldolase A in the surface biotinylation blot. Note that TgGRASP55 expression in mouse colon induces the cell surface expression of
immature core-glycosylated DF508-CFTR (band B).Surface Biotinylation and Surface ELISA
Surface biotinylation of CFTR was performed as described previously
(Han et al., 2006). Surface ELISA was performed using the extracellular
HA epitope-tagged CFTR construct as described previously (Gee et al.,
2010).758 Cell 146, 746–760, September 2, 2011 ª2011 Elsevier Inc.Real-Time and Reverse-Transcription PCR Analysis
RNA samples were subjected to the reverse-transcription (RT)-PCR reaction
with an AccuScript High Fidelity 1st Strand cDNA Synthesis Kit (Stratagene,
La Jolla, CA) according to the manufacturer’s instructions. Real-time RT-PCR
analyses were executed for evaluating efficiency of siRNAs.
Band-Shift Assay and Q-TOF-MS Analysis
For detection of GRASP55 phosphorylation, a band-shift assay and subse-
quent Q-TOF-MS analysis were performed. Detailed procedures are given in
the Extended Experimental Procedures.
Measurements of Cl Channel Activity and Shot-Circuit Current
Whole-cell recordings were performed on HEK293 cells as reported previously
(Namkung et al., 2005). For short-circuit current measurements, colon tissue
was stripped of connective tissue and muscle, opened longitudinally, and
mounted in an Ussing chamber (World Precision Instruments, Stevenage,
UK). Tissues were voltage-clamped at 0 mV with an EVC-4000 voltage clamp
(World Precision Instruments), and short-circuit currents (Isc) were continu-
ously recorded with a PowerLab data acquisition system (AD Instruments,
Castle Hill, Australia).
Statistical and Survival Analyses
Results are presented as mean ± SEM for the indicated number of experi-
ments. Statistical analysis of continuous data was performed with Student’s
t test or with analysis of variance followed by Tukey’s multiple comparison
test, as appropriate. Pearson’s chi-square test was applied to analyze the
quantal data of Cl– currents in cells expressing DF508-CFTR. Survival analysis
was performed with the Kaplan-Meier method and differences between the
groups were analyzed by the log-rank method. p < 0.05 was considered statis-
tically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at doi:10.1016/j.
cell.2011.07.021.
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